Showing results (21-30 of 162) with videos related to
Sort By:
Pageof 17
Biochemical and Biophysical Research Communications|November 15, 1988
NAD(P)H-dependent reduction of 12-ketoeicosatetraenoic acid to 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by rat liver microsomesJ P Falgueyret, Y Leblanc, J Rokach, et al.Biomedical & Environmental Mass Spectrometry|July 1, 1990
Analysis of domoic acid and related compounds by mass spectrometry and gas chromatography/mass spectrometry as N-trifluoroacetyl-O-silyl derivativesS Pleasance, M Xie, Y LeBlanc, et al.Wiley Interdisciplinary Reviews. Cognitive Science|August 26, 2015
Theory of mindStephanie M Carlson, Melissa A Koenig, Madeline B HarmsEuropean Journal of Haematology|September 1, 1995
Mixed haematopoietic colony formation via immature blast cell clusters on foetal mesenchymal cell layers distinguishes stem cells from peripheral blood, cord blood, bone marrow and blood stem cells mobilized by granulocyte-macrophage colony-stimulating factorB Harms, S Burdach, U Goebel, et al.Surgery|July 1, 1982
Acute versus sustained hypoproteinemia and posttraumatic pulmonary edemaR H Demling, B Harms, G Kramer, et al.Geburtshilfe Und Frauenheilkunde|November 1, 1991
[Ovarian pregnancy after gamete transfer (gift). A case report]F Lehmann, N Baban, B Harms, et al.Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|December 27, 1978
[Contents of glycogen, glycolytic activity and contents of metabolites in the atrioventricular system of bovine hearts (author's transl)]W Thorn, D Nitsche, B Harms, et al.Mabs|July 8, 2020
Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometryG Rouby, N T Tran, Y Leblanc, et al.Cytokine|March 1, 1996
Filgrastim (RHG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsisM Weiss, W Gross-Weege, B Harms, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 12, 1998
Initial experience with quality assurance of multi-institutional 3D radiotherapy clinical trials. A brief reportJ A Purdy, W B Harms, J Michalski, et al.Pageof 17